Touzart et al. recently reported that promoter methylation of the ASNS gene was associated with ASNase sensitivity in both T-ALL cell lines and patient-derived xenografts, and that ASNS promoter methylation was a prognostic factor for patients with T-ALL [14]. This evidence concerns the gene ASNS and acute lymphoblastic leukemia.